Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherman

Showing results (561-570 of 1,108) with videos related to

Pageof 111
Sort By:
Obstetrics and Gynecology|July 1, 1992
High- versus low-dose oxytocin for labor stimulationA J Satin, K J Leveno, M L Sherman, et al.
Biochemical Pharmacology|July 5, 1991
Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cellsS H Bernstein, M L Sherman, R Hass, et al.
Archives of Internal Medicine|June 1, 1989
Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter studyA K Rao, G C White, L Sherman, et al.
Journal of Computer Assisted Tomography|November 1, 1988
Cerebral venous angiomas: MR findingsV E Toro, C A Geyer, J L Sherman, et al.
Sports Medicine and Arthroscopy Review|February 3, 2022
Postoperative Infection: Prevention, Diagnosis, and Treatment Guidelines for the Sports SurgeonW Michael Pullen, Adam J Money, Taylor E Ray, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 1997
Spectral analysis of a thalamus-to-cortex seizure pathwayD L Sherman, Y C Tsai, L A Rossell, et al.
Video Journal of Sports Medicine|June 20, 2025
Medial Implantable Shock Absorber (MISHA) to Treat Medial Knee Arthritis in an Active PatientYazdan Raji, Begum Topkarci, Monica S Vel, et al.
Orthopaedic Journal of Sports Medicine|October 12, 2023
Association of Hip Dysplasia With Trochlear Dysplasia in Skeletally Mature PatientsAndrew T Fithian, Ann E Richey, Seth L Sherman, et al.
Epilepsia|March 5, 2003
Anterior thalamic mediation of experimental seizures: selective EEG spectral coherenceMarek A Mirski, Yien Che Tsai, Lisa Ann Rossell, et al.
Investigational New Drugs|November 27, 2002
Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapseMark S Berger, Lance H Leopold, James A Dowell, et al.
Pageof 111

Showing results (561-570 of 1,108) with videos related to

Sort By:
Pageof 111
Obstetrics and Gynecology|July 1, 1992
High- versus low-dose oxytocin for labor stimulationA J Satin, K J Leveno, M L Sherman, et al.
Biochemical Pharmacology|July 5, 1991
Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cellsS H Bernstein, M L Sherman, R Hass, et al.
Archives of Internal Medicine|June 1, 1989
Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter studyA K Rao, G C White, L Sherman, et al.
Journal of Computer Assisted Tomography|November 1, 1988
Cerebral venous angiomas: MR findingsV E Toro, C A Geyer, J L Sherman, et al.
Sports Medicine and Arthroscopy Review|February 3, 2022
Postoperative Infection: Prevention, Diagnosis, and Treatment Guidelines for the Sports SurgeonW Michael Pullen, Adam J Money, Taylor E Ray, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 1997
Spectral analysis of a thalamus-to-cortex seizure pathwayD L Sherman, Y C Tsai, L A Rossell, et al.
Video Journal of Sports Medicine|June 20, 2025
Medial Implantable Shock Absorber (MISHA) to Treat Medial Knee Arthritis in an Active PatientYazdan Raji, Begum Topkarci, Monica S Vel, et al.
Orthopaedic Journal of Sports Medicine|October 12, 2023
Association of Hip Dysplasia With Trochlear Dysplasia in Skeletally Mature PatientsAndrew T Fithian, Ann E Richey, Seth L Sherman, et al.
Epilepsia|March 5, 2003
Anterior thalamic mediation of experimental seizures: selective EEG spectral coherenceMarek A Mirski, Yien Che Tsai, Lisa Ann Rossell, et al.
Investigational New Drugs|November 27, 2002
Licensure of gemtuzumab ozogamicin for the treatment of selected patients 60 years of age or older with acute myeloid leukemia in first relapseMark S Berger, Lance H Leopold, James A Dowell, et al.
Pageof 111